Lymph node metastasis in lower lip squamous cell carcinoma in relation to tumour size, histologic variables and p27Kip1 protein expression

Oral Oncology

Volumn 40, Issue 1, 2004, Pages 92-98

  Rodolico, Vito ^a,b   Barresi, Elisa ^a   Di Lorenzo, Roberto ^a   Leonardi, Vincenza ^a   Napoli, Pietro ^a   Rappa, Francesca ^a   Di Bernardo, Cristofaro ^a  

^a UNIVERSITY OF PALERMO   (Italy)

^b NONE   (Italy)

Author keywords

Lower lip; Lymph node metastasis; p27Kip1; Squamous cell carcinoma; Tumour thickness

Indexed keywords

PROTEIN P27;

ADULT; AGED; ARTICLE; CANCER GRADING; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LIP CARCINOMA; LIP RECONSTRUCTION; LOWER LIP; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MICROSCOPY; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; SQUAMOUS CELL CARCINOMA; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; SURGICAL TECHNIQUE; THICKNESS; TUMOR VOLUME;

EID: 0344234402     PISSN: 13688375     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1368-8375(03)00141-6     Document Type: Article

References (33)

1. Hendricks J.L., Mendelson B.C., Woods J.E. Invasive carcinoma of the lower lip. Surg Clin North Am. 57:1977;837-844.
2. Baker S.R., Krause C.J. Carcinoma of the lip. Laryngoscope. 90:1980;19-27.
3. Nuutinen J., Karja J. Local and distant metastases in patients with surgically treated squamous cell carcinoma of the lip. Clin Otolaryngol. 6:1981;415-419.
4. Frierson H.F. Jr., Cooper P.H. Prognostic factors in squamous cell carcinoma of the lower lip. Hum Pathol. 17:1986;346-354.
5. Moore C., Flynn M.B., Greenberg R.A. Evaluation of size in prognosis of oral cancer. Cancer. 58:1986;158-162.
6. Beltrami C.A., Desinan L., Rubini C. Prognostic factors in squamous cell carcinoma of the oral cavity. A retrospective study of 80 cases. Pathol Res Pract. 188:1992;510-516.
7. Polyak K., Kato J.Y., Solomon M.J.et al. p27kip1, A cyclin-Cdk inhibitor, links transforming growth factor-b and contact inhibition to cell cycle arrest. Genes Dev. 8:1994;9-22.
8. MacLachlan T.K., Sang N., Giordano A. Cyclins, cyclin-dependent kinases and Cdk inhibitors. implications in cell cycle control and cancer Crit Rev Eukaryot Gene Expr. 5:1995;127-156.
9. Sherr C.J., Roberts J.M. Inhibitors of mammalian G1 cyclindependent kinases. Genes Dev. 9:1995;1149-1163.
10. Sgambato A., Cittadini A., Faraglia B.et al. Multiple function of p27kip1 and its alterations in tumor cells: a review. J. Cell. Physiol. 183:2000;18-27.
11. Kawamata N., Morosetti R., Miller C.W.et al. Molecular analysis of the cyclin-dependent kinase inhibitor gene p27Kip1 in human malignances. Cancer Res. 55:1995;2266-2269.
12. Ponce-Castaneda M.V., Lee M.H., Latres E.et al. p27kip1: chromosomal mapping to 12p12-12p13.1 and absence of mutations in human tumors. Cancer Res. 55:1995;1211-1214.
13. Shiohara M., El-Deiry W.S., Wada M.et al. Absence of WAF1 mutations in a variety of human malignancies. Blood. 84:1994;3781-3784.
14. Loda M., Cukor B., Tam S.W.et al. Increased proteasomedependent degradation of the cyclin-dependent kinase inhibitor p27 in aggressive colorectal carcinomas. Nat Med. 3:1997;231-233.
15. Ishihara S., Minato K., Hoshino H.et al. The cyclin-dependent kinase inhibitor p27 as a prognostic factor in advanced non small cell lung cancer: Its immunohistochemical evaluation using biopsy specimens. Lung Cancer. 26:1999;187-194.
16. Kudo Y., Takata T., Yasui W.et al. Reduced expression of cyclin-dependent kinase inhibitor p27Kip1 is an indicator of malignant behavior in oral squamous cell carcinoma. Cancer. 83:1998;2447-2455.
17. Mineta H., Miura K., Suzuki I.et al. Low p27 expression correlates with poor prognosis for patients with oral tongue squamous cell carcinoma. Cancer. 85:1999;1011-1017.
18. Venkatesan T.K., Kuropkat C., Caldarelli D.D.et al. Prognostic significance of p27 expression in carcinoma of the oral cavity and oropharynx. Laryngoscope. 109:1999;1329-1333.
19. Catzavelos C., Bhattacharya N., Ung Y.C.et al. Decreased levels of the cell-cycle inhibitor p27Kip1 protein: prognostic implications in primary breast cancer. Nat Med. 3:1997;227-230.
20. Tsihlias J., Kapusta L.R., DeBoer G.et al. Loss of cyclin-dependent kinase inhibitor p27Kip1 is a novel prognostic factor in localized human prostate adenocarcinoma. Cancer Res. 58:1998;542-548.
21. Esposito V., Baldi A., De Luca A.et al. Prognostic role of the cyclin-dependent kinase inhibitor p27 in non-small cell lung cancer. Cancer Res. 57:1997;3381-3385.
22. Sobin L.H., Wittekind C. UICC TMN classification of malignant tumours. 5th ed. 1997;Wiley & Sons, New York.
23. Anneroth G., Hansen L.S. A methodologic study of histologic classification and grading of malignancy in oral squamous cell carcinoma. Scand J Dent Res. 92:1984;448-468.
24. Friedman H.I., Cooper P.H., Wanebo H.J. Prognostic and therapeutic use of microstaging of cutaneous squamous cell carcinoma of the trunk and extremities. Cancer. 56:1985;1099-1105.
25. Crissman J.D., Makuch R., Budhraja M. Histopathologic grading of squamous cell carcinoma of the uterine cervix. An evaluation of 70 stage Ib patients. Cancer. 55:1985;1590-1596.
26. Klijanienko J., el-Naggar A.K., de Braud F.et al. Tumor vascularization, mitotic index, histopathologic grade, and DNA ploidy in the assessment of 114 head and neck squamous cell carcinomas. Cancer. 75:1995;1649-1656.
27. Croix B.S., Florenes V.A., Rak J.W.et al. Impact of the cyclindependent kinase inhibitor p27Kip1 on resistance of tumor cells to anticancer agents. Nat Med. 2:1996;1204-1210.
28. Fang F., Orend G., Watanabe N.et al. Dependence of cyclin ECDK2 kinase activity on cell anchorage. Science. 271:1996;499-502.
29. Levenberg S., Yarden A., Kam Z.et al. p27 is involved in Ncadherin-mediated contact inhibitor of cell growth and S-phase entry. Oncogene. 18:1999;869-876.
30. Thomas G.V., Szigeti K., Murphy M.et al. Down-regulation of p27 is associated with development of colorectal adenocarcinoma metastases. Am J Pathol. 153:1998;681-687.
31. Katayose Y., Kim M., Rakkar A.N.S.et al. Promoting apoptosis: A novel activity associated with the cyclin-dependent kinase inhibitor p27. Cancer Res. 57:1997;5441-5445.
32. Hiromura K., Pippin J.W., Fero M.L.et al. Modulation of apoptosis by cyclin-dependent kinase inhibitor p27Kip1. J. Clin. Invest. 103:1999;597-604.
33. Wang Z., Gorospe M., Huang Y.et al. P27KIP1 overexpression causes apoptotic death of mammalian cells. Oncogene. 15:1997;2991-2997.